| scholarly article | Q13442814 |
| P2093 | author name string | Ie-Ming Shih | |
| Jung-Hye Choi | |||
| Kyung-Tae Lee | |||
| Ji-Hye Ahn | |||
| Yeong-In Yang | |||
| P2860 | cites work | Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription | Q24292159 |
| HBXAP, a novel PHD-finger protein, possesses transcription repression activity | Q24293970 | ||
| The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
| Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells | Q24319922 | ||
| Functional analysis of the subunits of the chromatin assembly factor RSF | Q24322794 | ||
| Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma | Q24536023 | ||
| CREB-binding protein/p300 are transcriptional coactivators of p65 | Q24569596 | ||
| Chemoresistance in human ovarian cancer: the role of apoptotic regulators | Q24791433 | ||
| NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
| DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1 | Q28215916 | ||
| Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma | Q28474516 | ||
| Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 | Q28619230 | ||
| Mechanisms of cancer drug resistance | Q29615849 | ||
| NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 | ||
| Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells | Q33181379 | ||
| NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. | Q33959017 | ||
| CBP and p300: HATs for different occasions | Q33980693 | ||
| Options for modulation of drug resistance in ovarian cancer. | Q34176120 | ||
| Functional interaction between nuclear matrix-associated HBXAP and NF-kappaB. | Q34332157 | ||
| Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability. | Q34352173 | ||
| Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma | Q34839580 | ||
| Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs | Q36085634 | ||
| Current insights into the regulation of programmed cell death by NF-kappaB. | Q36637900 | ||
| Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy | Q36666787 | ||
| The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1. | Q37066492 | ||
| Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. | Q37101421 | ||
| A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer | Q37165130 | ||
| Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells | Q38310149 | ||
| NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells | Q38358712 | ||
| Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex. | Q39187272 | ||
| Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway | Q39268041 | ||
| Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma | Q39333697 | ||
| Rsf-1 is overexpressed in non-small cell lung cancers and regulates cyclinD1 expression and ERK activity | Q39386256 | ||
| Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro | Q39969399 | ||
| Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells | Q40150720 | ||
| Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models | Q40486780 | ||
| The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. | Q41203811 | ||
| The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. | Q41284359 | ||
| Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. | Q42483178 | ||
| IkappaB kinase activation is involved in regulation of paclitaxel-induced apoptosis in human tumor cell lines | Q43830219 | ||
| Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization | Q45182288 | ||
| TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity | Q73209285 | ||
| Focus on epithelial ovarian cancer | Q75353680 | ||
| Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival | Q79915423 | ||
| Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma | Q80180274 | ||
| Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma | Q82495498 | ||
| Rsf-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer | Q83976198 | ||
| Rsf-1/HBXAP overexpression is associated with disease-specific survival of patients with gallbladder carcinoma | Q85088471 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| NF-κB | Q411114 | ||
| P304 | page(s) | 2258-2269 | |
| P577 | publication date | 2014-02-24 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance | |
| P478 | volume | 74 |
| Q35016695 | BRD4 inhibitor inhibits colorectal cancer growth and metastasis |
| Q39433158 | Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy |
| Q38709544 | Epigenomic regulation of oncogenesis by chromatin remodeling |
| Q47962320 | Expansion of the ISWI chromatin remodeler family with new active complexes. |
| Q61809784 | High Expression Levels of AGGF1 and MFAP4 Predict Primary Platinum-Based Chemoresistance and are Associated with Adverse Prognosis in Patients with Serous Ovarian Cancer |
| Q37697068 | Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB. |
| Q35213374 | ICan: an integrated co-alteration network to identify ovarian cancer-related genes |
| Q88131382 | LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway |
| Q38948577 | Myeloid differentiation factor 88 promotes cisplatin chemoresistance in ovarian cancer |
| Q35732942 | Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer |
| Q37514072 | Nucleophosmin Mutations Induce Chemosensitivity in THP-1 Leukemia Cells by Suppressing NF-κB Activity and Regulating Bax/Bcl-2 Expression |
| Q37675934 | RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-κB signaling pathway in nasopharyngeal carcinoma |
| Q47114885 | Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling |
| Q50331571 | Remodeling and spacing factor 1 overexpression is associated with poor prognosis in renal cell carcinoma |
| Q99634863 | The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response |
| Q33873642 | p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells. |
Search more.